139 related articles for article (PubMed ID: 21880414)
21. Beta-catenin/LEF1 activated enamelin expression in ameloblast-like cells.
Tian H; Lv P; Ma K; Zhou C; Gao X
Biochem Biophys Res Commun; 2010 Jul; 398(3):519-24. PubMed ID: 20599763
[TBL] [Abstract][Full Text] [Related]
22. Wnt antagonist gene DKK2 is epigenetically silenced and inhibits renal cancer progression through apoptotic and cell cycle pathways.
Hirata H; Hinoda Y; Nakajima K; Kawamoto K; Kikuno N; Kawakami K; Yamamura S; Ueno K; Majid S; Saini S; Ishii N; Dahiya R
Clin Cancer Res; 2009 Sep; 15(18):5678-87. PubMed ID: 19755393
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of bcl-2 enhances the efficacy of chemotherapy in renal cell carcinoma.
Kausch I; Jiang H; Thode B; Doehn C; Krüger S; Jocham D
Eur Urol; 2005 May; 47(5):703-9. PubMed ID: 15826766
[TBL] [Abstract][Full Text] [Related]
24. Blockade of epidermal growth factor receptor signaling leads to inhibition of renal cell carcinoma growth in the bone of nude mice.
Weber KL; Doucet M; Price JE; Baker C; Kim SJ; Fidler IJ
Cancer Res; 2003 Jun; 63(11):2940-7. PubMed ID: 12782601
[TBL] [Abstract][Full Text] [Related]
25. Silibinin inhibits the invasion and migration of renal carcinoma 786-O cells in vitro, inhibits the growth of xenografts in vivo and enhances chemosensitivity to 5-fluorouracil and paclitaxel.
Chang HR; Chen PN; Yang SF; Sun YS; Wu SW; Hung TW; Lian JD; Chu SC; Hsieh YS
Mol Carcinog; 2011 Oct; 50(10):811-23. PubMed ID: 21574189
[TBL] [Abstract][Full Text] [Related]
26. Overexpression of DLC-1 induces cell apoptosis and proliferation inhibition in the renal cell carcinoma.
Zhang T; Zheng J; Jiang N; Wang G; Shi Q; Liu C; Lu Y
Cancer Lett; 2009 Sep; 283(1):59-67. PubMed ID: 19380190
[TBL] [Abstract][Full Text] [Related]
27. Pyrvinium Sensitizes Clear Cell Renal Cell Carcinoma Response to Chemotherapy Via Casein Kinase 1α-Dependent Inhibition of Wnt/β-Catenin.
Cui L; Zhao J; Liu J
Am J Med Sci; 2018 Mar; 355(3):274-280. PubMed ID: 29549930
[TBL] [Abstract][Full Text] [Related]
28. Methylation of the gamma-catenin gene is associated with poor prognosis of renal cell carcinoma.
Breault JE; Shiina H; Igawa M; Ribeiro-Filho LA; Deguchi M; Enokida H; Urakami S; Terashima M; Nakagawa M; Kane CJ; Carroll PR; Dahiya R
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):557-64. PubMed ID: 15701841
[TBL] [Abstract][Full Text] [Related]
29. Up-regulation of connexin 32 gene by 5-aza-2'-deoxycytidine enhances vinblastine-induced cytotoxicity in human renal carcinoma cells via the activation of JNK signalling.
Takano Y; Iwata H; Yano Y; Miyazawa M; Virgona N; Sato H; Ueno K; Yano T
Biochem Pharmacol; 2010 Aug; 80(4):463-70. PubMed ID: 20510207
[TBL] [Abstract][Full Text] [Related]
30. Transcriptional regulation of MMP13 by Lef1 in chondrocytes.
Yun K; Im SH
Biochem Biophys Res Commun; 2007 Dec; 364(4):1009-14. PubMed ID: 17971297
[TBL] [Abstract][Full Text] [Related]
31. Restoration of expression of transforming growth factor-beta type II receptor in murine renal cell carcinoma (renca) cells by 5-Aza-2'-deoxycytidine.
Zhang Q; Rubenstein JN; Liu VC; Park I; Jang T; Lee C
Life Sci; 2005 Jan; 76(10):1159-66. PubMed ID: 15620579
[TBL] [Abstract][Full Text] [Related]
32. The osteogenic differentiation of human adipose-derived stem cells is regulated through the let-7i-3p/LEF1/β-catenin axis under cyclic strain.
Luo Y; Ge R; Wu H; Ding X; Song H; Ji H; Li M; Ma Y; Li S; Wang C; Du H
Stem Cell Res Ther; 2019 Nov; 10(1):339. PubMed ID: 31753039
[TBL] [Abstract][Full Text] [Related]
33. Receptors for luteinizing hormone releasing hormone expressed on human renal cell carcinomas can be used for targeted chemotherapy with cytotoxic luteinizing hormone releasing hormone analogues.
Keller G; Schally AV; Gaiser T; Nagy A; Baker B; Halmos G; Engel JB
Clin Cancer Res; 2005 Aug; 11(15):5549-57. PubMed ID: 16061872
[TBL] [Abstract][Full Text] [Related]
34. Decreased expression of bone morphogenetic protein (BMP) receptor type II correlates with insensitivity to BMP-6 in human renal cell carcinoma cells.
Kim IY; Lee DH; Lee DK; Kim BC; Kim HT; Leach FS; Linehan WM; Morton RA; Kim SJ
Clin Cancer Res; 2003 Dec; 9(16 Pt 1):6046-51. PubMed ID: 14676131
[TBL] [Abstract][Full Text] [Related]
35. [The effect of calcyclin binding protein on gastric cancer cell proliferation].
Ning XX; Sun SR; Li Y; Gong WQ; Liu LL; Sun L; Liang J; Pan YL; Cheng Y; Wu KC; Fan DM
Zhonghua Yi Xue Za Zhi; 2006 Dec; 86(46):3264-8. PubMed ID: 17313807
[TBL] [Abstract][Full Text] [Related]
36. Delineation of apoptotic genes for synergistic apoptosis of lexatumumab and anthracyclines in human renal cell carcinoma cells by polymerase chain reaction array.
Jin X; Wu XX; Jin C; Inui M; Sugimoto M; Kakehi Y
Anticancer Drugs; 2012 Apr; 23(4):445-54. PubMed ID: 22205156
[TBL] [Abstract][Full Text] [Related]
37. beta-catenin siRNA regulation of apoptosis- and angiogenesis-related gene expression in hepatocellular carcinoma cells: potential uses for gene therapy.
Wang XH; Sun X; Meng XW; Lv ZW; Du YJ; Zhu Y; Chen J; Kong DX; Jin SZ
Oncol Rep; 2010 Oct; 24(4):1093-9. PubMed ID: 20811694
[TBL] [Abstract][Full Text] [Related]
38. Expression patterns of hair and epithelial keratins and transcription factors HOXC13, LEF1, and beta-catenin in a malignant pilomatricoma: a histological and immunohistochemical study.
Cribier B; Worret WI; Braun-Falco M; Peltre B; Langbein L; Schweizer J
J Cutan Pathol; 2006 Jan; 33(1):1-9. PubMed ID: 16441405
[TBL] [Abstract][Full Text] [Related]
39. Wnt inhibitory factor 1 induces apoptosis and inhibits cervical cancer growth, invasion and angiogenesis in vivo.
Ramachandran I; Thavathiru E; Ramalingam S; Natarajan G; Mills WK; Benbrook DM; Zuna R; Lightfoot S; Reis A; Anant S; Queimado L
Oncogene; 2012 May; 31(22):2725-37. PubMed ID: 22002305
[TBL] [Abstract][Full Text] [Related]
40. Differentiation-inducing factor-1 alters canonical Wnt signaling and suppresses alkaline phosphatase expression in osteoblast-like cell lines.
Matsuzaki E; Takahashi-Yanaga F; Miwa Y; Hirata M; Watanabe Y; Sato N; Morimoto S; Hirofuji T; Maeda K; Sasaguri T
J Bone Miner Res; 2006 Aug; 21(8):1307-16. PubMed ID: 16869729
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
